ANN ARBOR – Aastrom Biosciences has created a new position ? Vice President Global Research ? and appointed Indiana University professor Janet Hock to the post. Hock will be responsible for Aastrom’s biological research efforts including the bone and tissue regeneration research programs and related clinical development activities.
“In selecting Dr. Hock as Aastrom’s first Vice President Global Research, we have appointed an individual who possesses a rare combination of proven business leadership capabilities and highly respected scientific credentials,” said Aastrom CEO R. Douglas Armstrong. “Her expertise and successes in regenerative medicine and the pharmaceutical industry are an ideal match for Aastrom as we develop and move our Tissue Repair Cell technology into the clinic for a variety of medical indications.”
Hock has broad experience in the fields of bone formation and skeletal diseases, along with the development of new therapeutic treatments. Aastrom said her background will strongly support the company’s progress in moving its tissue regeneration products through the clinical development stage.
She joins Aastrom from her current position on the faculty of the Indiana University Schools of Medicine and Dentistry, where she is Professor, Department of Anatomy and Cell Biology, School of Medicine, and Professor, Department of Periodontics, School of Dentistry. Hock was also program director and founder of the Indiana University Cancer Center Bone Cancers Research program, and founder of Thetis Consulting LLC, a scientific advisory firm focused on the treatment of skeletal diseases and bone cancer.
Previously she was employed by Eli Lilly and Company to lead the discovery and development of anabolic drugs for the treatment of osteoporosis. She served in various senior technology development positions including: Senior Research Advisor for Product Development, Head of the Bone Formation Group, Director of the Skeletal Diseases Research Group, and Product Team Research Advisor/Chief Scientific Officer.
